fda compounding semaglutide enforcement 2025 news Patients struggle as compounded GLP-1 access rapidly shrinks Digital Health Law Firm |

Retatrutide is not yet FDA-approved and is available primarily through grey market channels

If retatrutide is used regardless of this risk, patients require explicit information on what symptoms to monitor for and when to seek assistance

Neither cagrilintide nor retatrutide is currently licensed in the UK, so neither is available through NHS or private prescribing routes

Each released batch is supported by Janoshik source-lab documentation, independent Testide Canada Laboratory verification, and LAL endotoxin screening through Testide for supported batches

In a large RCT involving obese and prediabetic individuals, tirzepatide significantly delayed the onset of T2DM compared with placebo across multiple doses, with sustained benefits observed during long-term follow-up

Unusual odor from the vial suggests bacterial contamination or significant chemical breakdown